Price
Target price
€288.60
€288.60
0.000%
-
0.000%
€300.95
15:37 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
There is no change in the price for West Pharmaceutical Services Inc. today.
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
With a target price of 300 € there is a slightly positive potential of 3.95% for West Pharmaceutical Services Inc. compared to the current price of 288.6 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 0.000% | -7.884% | -5.222% | 28.610% | 23.175% | -15.466% | -10.871% |
| Bio-Rad Labs Inc. A | 4.180% | 5.779% | 6.102% | 27.439% | 7.871% | -26.866% | -52.034% |
| CONMED Corp. | -0.530% | 0.535% | 22.876% | -10.476% | 7.429% | -65.505% | -66.726% |
| Penumbra Inc | 0.140% | 0.575% | 0.503% | 42.067% | 5.030% | 2.868% | 22.612% |
Comments
West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $447.00 price target on the stock.
Show more
Ratings data for WST provided by MarketBeat
